Zachary Wolfe

Zachary Wolfe practices at Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University.

Zachary Wolfe's NPI, 1164809547, was assigned on May 5, 2015. Zachary Wolfe graduated from Geisinger Commonwealth School of Medicine in 2015. Zachary Wolfe holds Pennsylvania license MD472564.

Zachary Wolfe's primary practice is Lehigh Valley Hospital-Cedar Crest, at 1200 South Cedar Crest Boulevard, Allentown, PA 18103 in Lehigh County. The practice phone is (610) 402-8000.

Zachary Wolfe's primary practice is Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University. Zachary Wolfe is also affiliated with Community Hospital East. The medical group on file is Lehigh Valley Physician Group (LVPG), Pocono. Dmand AI also links Zachary Wolfe to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Zachary Wolfe practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Zachary Wolfe's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Zachary Wolfe is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Zachary Wolfe's licenses on file in 2 states: Pennsylvania and Indiana.

Dmand AI lists chronic anemia, chronic embolism thrombosis, chronic leukemia, deep vein thrombosis (DVT), fluid and electrolyte imbalances, immune deficiency disease, lymphoma and multiple myeloma among the conditions Zachary Wolfe treats.

CMS data shows 921 Medicare services from Zachary Wolfe across 7 procedure codes in 2024, for 274 Medicare patients. Medicare paid $70,326 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 274 Medicare patients who saw Zachary Wolfe in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Zachary Wolfe's median patient age at 68, with 61% women.

In 2024, Zachary Wolfe wrote 903 Medicare Part D claims for 148 patients. 63% of them were for generic drugs. CMS names the drug for 680 of them, across 23 drugs with 11 or more claims each, at $3,979,346 in total drug cost. In 2023, CMS named 557 claims across 16 drugs.

Zachary Wolfe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Zachary Wolfe, published from 2017 to 2022. 2017 was the busiest year, with 4. Zachary Wolfe has published most often in Cureus. Zachary Wolfe's most frequent co-authors are Bradley Walter Lash, MD, Umashankar K. Ballehaninna, MD and Aaron Udell Blackham, MD.

Dmand AI links Zachary Wolfe to 1 clinical trial. Conditions studied include Adenocarcinoma Of Esophagus.

CMS Open Payments shows 8 general payments to Zachary Wolfe from 5 drug and device companies from 2016 to 2025. Education make up the largest share, 62% of the total. Incyte Corporation paid the most, $378.

Dmand AI lists 1 award for Zachary Wolfe.

Zachary Wolfe graduated from Geisinger Commonwealth School of Medicine in 2015. Zachary Wolfe is a member of AOA and ACP.

Zachary Wolfe is in network with 10 carriers, including Elevance, Aetna and Highmark. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.